
GC30978
PDE10-IN-1
Also known as 2-[(1R,2R)-2-(5,8-dimethyl-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)cyclopropyl]-3-methylimidazo[2,1-f][1,6]naphthyridine
PDE10-IN-1 is a potent PDE10-IN-1 inhibitor extracted from Patent WO 2013192273 A1, for treating CNS and metabolic disorders
ChemicalCAS1516896-09-5MW369.42FormulaC21H19N7
- CAS number
- 1516896-09-5
- Molecular weight
- 369.42
- Formula
- C21H19N7
- Solubility
- DMSO : 2 mg/mL (5·41 mM)
- InChIKey
- ZLHNYULRKIEGAY-HZPDHXFCSA-N
- Catalogue number
- GC30978
- Brand
- GLPBIO
Computed properties PubChem CID 72709059 · XLogP 3 · TPSA 73.3 Ų · H-bond donors 0
- XLogP
- 3
- TPSA
- 73.3 Ų
- H-bond donors
- 0
- H-bond acceptors
- 5
- Rotatable bonds
- 2
- Heavy atoms
- 28
SMILES CC1=CN=C(C2=NC(=NN12)[C@@H]3C[C@H]3C4=C(N5C=CC6=C(C5=N4)C=CC=N6)C)C
Computed descriptors from PubChem (CID 72709059), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il